Experience
-
Bristol Myers Squibb ()
-
Vice President, Franchise Head - Global Program Leadership, Hematology and Cell Therapy
Apr 2026 - Present · 4 mos
Leading global program leadership for hematology, cell therapy across therapeutic areas, and the established brands portfolio.
-
Vice President, Global Program Lead, Hematology-Oncology
Sep 2023 - Mar 2026 · 2 yrs 7 mos
Leading global programs for golcadomide and BCL6-LDD, first in class targeted protein degraders for the treatment of Lymphoma
-
Gilead Sciences (3 yrs 7 mos)
-
Executive Director, Global Commercial Product Strategy, Oncology
Nov 2020 - Sep 2023 · 2 yrs 11 mos
Led global commercialization of Trodelvy across various tumor types, with focus on breast cancer.
-
Executive Director, Inflammation Marketing, IBD
Mar 2020 - Nov 2020 · 9 mos
Led US marketing for Inflammatory Bowel Diseases (IBD) for filgotinib
-
Genentech (4 yrs 9 mos)
-
Marketing Team Director (TL2), Hematology-Oncology
Jun 2019 - Mar 2020 · 10 mos
Led team of 9 marketers supporting Venclexta across indications and the hematology-oncology franchise
-
Senior Marketing Manager, Hematology-Oncology
Aug 2018 - May 2019 · 10 mos
Led marketing activities for Venclexta in CLL and Polivy launch in DLBCL
-
Senior Product Manager, HCP Promotions, Esbriet, Respiratory
Sep 2016 - Aug 2018 · 2 yrs
Led HCP marketing activities and new launch for Esbriet in idiopathic pulmonary fibrosis (IPF)
-
Roche (5 yrs 3 mos)
-
Regulatory Program Director, Oncology
Mar 2014 - Jun 2015 · 1 yr 4 mos
Regulatory lead for HER2+ early and metastatic Breast cancer global program
-
Associate Regulatory Program Director, Oncology
Sep 2012 - Feb 2014 · 1 yr 6 mos
Regulatory lead for HER2+ early and metastatic Breast cancer global program
-
Associate Regulatory Program Director, Oncology
Apr 2012 - Aug 2012 · 5 mos
Regulatory lead for US skin cancer and global liver cancer programs
-
Global Regulatory Affairs Fellow at Schering-Plough
Jul 2008 - Apr 2010 · 1 yr 10 mos